We have generated a CPC-specific DNAm signature which includes several important genes such as AK1, PER2, and PLSCR4. This signature is highly specific when compared to other brain tumors highlighting its potential clinical diagnostic utility. This evidence concerns the gene PLSCR4 and brain neoplasm.